Disc Medicine annual return on equity
2022
2023
2024
2025
Disc Medicine Return on Equity (ROE) Growth & History (IRON)
Disc Medicine's return on equity was −35.86% for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −35.86% | −8.13 pp |
| 2024 | 2024-12-31 | −27.73% | +1.57 pp |
| 2023 | 2023-12-31 | −29.30% | +54.03 pp |
| 2022 | 2022-12-31 | −83.32% | — |
Disc Medicine quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −8.93% | −0.27 pp |
| Q1 2026 | 2026-03-31 | −8.89% | −2.72 pp |
| Q4 2025 | 2025-12-31 | −9.22% | −2.76 pp |
| Q3 2025 | 2025-09-30 | −10.50% | −4.94 pp |
| Q2 2025 | 2025-06-30 | −8.67% | −2.30 pp |
| Q1 2025 | 2025-03-31 | −6.18% | +1.71 pp |
| Q4 2024 | 2024-12-31 | −6.46% | +0.23 pp |
| Q3 2024 | 2024-09-30 | −5.56% | −1.69 pp |
| Q2 2024 | 2024-06-30 | −6.37% | −1.09 pp |
| Q1 2024 | 2024-03-31 | −7.89% | +3.24 pp |
| Q4 2023 | 2023-12-31 | −6.70% | +22.11 pp |
| Q3 2023 | 2023-09-30 | −3.87% | — |
| Q2 2023 | 2023-06-30 | −5.28% | — |
| Q1 2023 | 2023-03-31 | −11.13% | — |
| Q4 2022 | 2022-12-31 | −28.80% | −75.97 pp |
| Q4 2021 | 2021-12-31 | 47.16% | — |
| Q3 2021 | 2021-09-30 | −12.43% | — |
| Q2 2021 | 2021-06-30 | −10.00% | — |
| Q1 2021 | 2021-03-31 | −26.76% | — |
Disc Medicine return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Disc Medicine's return on equity increased from −83.32% to −35.86%, a change of +47.46 percentage points. The latest reported quarter, Q2 2026, shows −8.93%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗